Abstract
BackgroundViral-based immunotherapy can overcome resistance to immune checkpoint blockade (ICB) and fill the unmet needs of many patients with cancer. Oncolytic viruses (OVs) are defined as engineered or naturally occurring...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have